Department of Neurology News and Events

Massachusetts General Hospital reports on news from the Neurology Service on clinical trials, progress in neuroscience research, and recognition for clinical excellence.


Currently Browsing:2019

Currently Browsing:2018

Currently Browsing:2017

  • We are Recruiting a Medical Director for Neurology at York Hospital

    Wednesday, December 20, 2017  Mass General

    Massachusetts General Hospital Neurology Department – Medical Director for Neurology at York Hospital

  • NeuroBlast Fall 2017

    Thursday, December 7, 2017  Mass General

    Welcome to NeuroBlast, the newsletter of neurology, neurosurgery and psychiatry advances from the Massachusetts General Hospital Center for Neurosciences.

  • Noninvasive Brain Stimulation Aims to Reset Circuits to Treat Neuropsychiatric Conditions at Massachusetts General Hospital

    Wednesday, December 6, 2017  Mass General

    “Instead of just saying that a patient has depression, or schizophrenia, or stroke, or epilepsy, we focus on transdiagnostic problems such as maladaptive reward processing or amotivation, ineffective inhibitory control or impulsivity, dysexecutive effects such as poor planning or multitasking, et cetera,” says Joan A. Camprodon, MD, PhD, director of the Division of Neuropsychiatry at Mass General.

  • Going Big: How Massachusetts General Hospital Neurology is Using Big Data for Big Benefits

    Wednesday, December 6, 2017  Research

    “We’re building a research environment with tools and methods and procedures that can be shared and multiplied and made scalable enough to have a critical amount of information that could be interpreted for the benefit of patients,” says Alex Sherman, director of the NCRI’s Center for Innovation and Biomedical Informatics.

  • Mass General Pulls Together Multi-specialty Team to Treat Rare Disorder

    Monday, December 4, 2017  Clinical

    At 79, Tamar wasn’t ready to slow down: She walked three miles a day, was a whiz at Sudoku puzzles, and loved hiking with her husband. But within just a year, she had sharply declined. The once-vibrant septuagenarian could no longer get out of a chair unassisted, didn’t understand how to use a telephone, and had become incontinent. “She was a shell of her former self,” remembers her daughter Iris. “Her physician told us that she had atypical Alzheimer’s disease and that nothing could be done for her.”

  • We are Recruiting New Faculty with Expertise in Neuroengineering and Neurotechnology

    Wednesday, November 1, 2017  Mass General

    Center for Neurotechnology and Neurorecovery Massachusetts General Hospital Harvard Medical School

  • Phillips Society luncheon explores brain health

    Friday, September 29, 2017  Mass General

    Leaders of the MGH Interdisciplinary Brain Center and Neuroscience Institute shared their progress toward understanding, treating and preventing brain disorders at the 12th annual Phillips Society luncheon.

  • We are Recruiting New Faculty

    Tuesday, September 19, 2017  Mass General

    The Department of Neurology at Massachusetts General Hospital is recruiting new faculty.

  • The Ins and Outs of a Comprehensive Stroke Center: What Does It Mean?

    Wednesday, August 23, 2017  Mass General

    The Joint Commission recently certified Massachusetts General Hospital as an Advanced Comprehensive Stroke Center. This certification is designed to recognize the specific capabilities of hospitals that can treat the most complex stroke case. Mass General is the first hospital in Massachusetts to receive this certification.

  • ALS care brought to South Florida with help of MGH and patient gift

    Monday, July 10, 2017  Mass General

    MGH patient and Florida resident brings ALS care to his home state through gift.

  • NeuroBlast Spring 2017

    Monday, June 12, 2017  Research

    Welcome to NeuroBlast, the newsletter of neurology, neurosurgery and psychiatry advances from the Massachusetts General Hospital Center for Neurosciences.

  • Delivering the highest standards of care

    Friday, June 9, 2017  Mass General

    MGH Acute Stroke Service celebrates fifth annual Acute Stroke Breakfast Gala.

  • Genomics Studies Drive Trials of Personalized Treatment for Brain Tumors

    Wednesday, May 31, 2017  Research

    “We have international collaborators and now have more than a thousand brain mets in our bank that we’re going to analyze,” says Mass General Hospital’s neuro-oncologist Priscilla K. Brastianos, MD.

  • Understanding the Health Effects of Cannabis

    Wednesday, May 31, 2017  Research

    “We’ve got a growing for-profit industry that’s looking to encourage use of cannabis products, particularly among young people,” says psychiatrist Eden Evins, MD, MPH, Director of the Center for Addiction Medicine at Mass General Hospital. “There’s a reduced perception of harm and increased prevalence of use.”

  • Merit Cudkowicz, MD, MSc, Mass General Chief of Neurology, Answers Questions About the New FDA Approved Drug, Edaravone, to Treat ALS

    Monday, May 15, 2017  Clinical

    On May 5, the FDA approved a new drug — Edaravone — to treat ALS. This is the first approval of an ALS treatment that slows progression since Riluzole was approved 22 years ago, and incredibly good news for people living with ALS and the ALS field in general.

  • We are Recruiting New Faculty

    Thursday, May 11, 2017  Mass General

    The Department of Neurology at Massachusetts General Hospital is recruiting new faculty.

  • Breaking ALS News: FDA's approval of Radicava (Edaravone)

    Monday, May 8, 2017  Clinical

    Radicava™(Edaravone) has been approved by the FDA to treat ALS.

  • Take the challenge: Get fit and have fun

    Friday, April 28, 2017  Mass General

    To celebrate May as Stroke Awareness Month, the MGH Neurology Department will launch a #30x30StopStroke challenge with a goal of getting as many staff as possible to exercise 30 minutes a day for 30 days.

  • Research Roundup March 2017

    Friday, March 17, 2017  Mass General

    Research at the MGH is interwoven throughout more than 30 departments, centers and units, and is conducted with the support and guidance of the MGH Research Institute. The Research Roundup is a monthly series highlighting studies, news and events.

Currently Browsing:2016

  • Neurology Department honors John Stakes, MD

    Friday, December 9, 2016  Mass General

    The MGH Neurology Department has its very own Wizard of Oz. That wizard’s real name is John Stakes, MD, co-founder of the MGH Sleep Division and the Sleep Lab.

  • Blood Tests for Brain Cancer

    Friday, November 18, 2016  Mass General

    A Massachusetts General Hospital Neurosurgeon Works to Develop the First Blood-Based Test for Patients with Brain Tumors.

  • NeuroBlast Fall 2016

    Friday, November 18, 2016  Research

    Welcome to NeuroBlast, the newsletter of neurology, neurosurgery and psychiatry advances from the Massachusetts General Hospital Center for Neurosciences.

  • Once again, named among America's best hospitals

    Tuesday, August 2, 2016  Mass General

    Massachusetts General Hospital is once again named among the top hospitals in America by U.S. News & World Report and is the only hospital to be highly rated across all 16 specialties.

  • Mass General receives awards for exceptional stroke care

    Sunday, July 10, 2016  Mass General

    Massachusetts General Hospital has received two awards from the Paul Coverdell National Acute Stroke Program at the Massachusetts Department of Public Health.

  • Care team honored at fourth annual Stroke Breakfast Gala

    Friday, June 10, 2016  Mass General

    About 7:15 AM on Jan. 7, now 54-year-old Jang-Ho Cha, MD, PhD, translational medicine head for Neuroscience at Novartis, was going through his morning routine. Cha walked downstairs in his Boston home, made a pot of coffee, took a shower and put his contact lenses in. It was when he began brushing his teeth that he noticed something was wrong.

  • Seized: Inside the Mystery of Epilepsy

    Monday, May 23, 2016  Research

    Moving documentary on Epilepsy, featuring Mass General Epilepsy expert, Dr. Andrew Cole, Division Chief, Clinical Neurophysiology.

  • NeuroBlast Spring 2016

    Monday, May 16, 2016  Mass General

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, psychiatry, and neuroscience from Massachusetts General Hospital.

  • A Patient's Astonishing Recovery from Brain Trauma Provides Hope for New Treatments

    Friday, May 13, 2016  Clinical

    Dylan’s recovery has provided Dr. Edlow and his laboratory important information about the timeline used for prognosis in the case of traumatic brain injuries. The information has encouraged clinicians not to limit care too quickly, and has provided a measure of hope for families.

  • Focus on Functional Neurological Disorders

    Tuesday, January 19, 2016  Research

    “Many patients come in worried that they will not be heard. At our clinic, they learn that FND is a real neuropsychiatric condition, and if they meet the criteria, we provide a clear diagnosis,” says Dr. Perez

  • PET Theories: New Imaging Tools Offer Better Diagnosis, Treatment of Neurodegeneration

    Tuesday, January 19, 2016  Research

    “Making the correct molecular diagnosis is a critical step if we are to find medicines that work in people,” says Gomperts.

  • Innovations in Spinal Cord Tumor Surgery

    Tuesday, January 19, 2016  Research

    “Spinal cord monitoring requires a careful interplay between the surgeon, anesthesia, and the monitoring team. We’re really privileged to have such a dedicated group of individuals who have been with us quite a long time doing this work. It’s the teamwork that has allowed us to capitalize [on the new innovations],” Borges says.

  • Molecular Approach to Brain Tumors Improves Treatment

    Tuesday, January 19, 2016  Research

    “As we look to treat patients in the future, there is an emerging imperative to arrive at an integrated diagnosis,” says Cahill, one that encompasses both histological and molecular data.

  • NeuroBlast e-Newsletter January 2016

    Tuesday, January 19, 2016  Research

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

Currently Browsing:2015

  • Steve Gleason Act scores victory for ALS patients on Capitol Hill

    Wednesday, July 22, 2015  Mass General

    The bill, which now needs only Obama's signature to become a law, will make critical technology available to patients with ALS and other neurological disorders through Medicare and Medicaid. That includes innovative speech-generating devices like the one Gleason uses to type words through eye movements.

  • #1 in the Nation

    Tuesday, July 21, 2015  Mass General

    U.S. News & World Report has named Massachusetts General Hospital the #1 hospital in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

  • New Clinical Pilot Studies Will Use Biomarkers to Speed Therapy Development

    Monday, July 13, 2015  Research

    The ALS Association and the ALS Finding a Cure Foundation are pleased to announce $3 million in funding for two new Phase II clinical studies through the ALS Accelerated Therapeutics (ALS ACT) initiative.

  • Robert G. Miller awarded $1.5 million grant to help fund Neuraltus' Phase 2 clinical study

    Monday, July 13, 2015  Research

    The Phase 2 study is intended to help confirm the potential clinical benefits seen in the previous study of NP001, the results from which were published in the April 2015 issue of Neurology: Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology.

  • NeuroBlast e-Newsletter July 2015

    Thursday, July 9, 2015  Research

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • Testifying in support of TeleStroke

    Friday, June 5, 2015  Mass General

    As the momentum of TeleStroke grows, MGH doctors are supporting ways to expand this treatment to more patients - including testifying before the U.S. Senate in support of the Furthering Access to Stroke Telemedicine (FAST) Act.

  • Circadian Dysfunction in Parkinson's Disease

    Monday, June 1, 2015  Mass General

    New research from Massachusetts General Hospital investigates the role of circadian rhythm dysfunction in the pathophysiology of Parkinson’s disease.

  • MGH ALS Symposium Video

    Tuesday, May 12, 2015  Research

    Hear from the MGH Neurology Department researchers and clinic staff dedicated to finding treatments and cures for ALS.

  • Endovascular Clot Retrieval Therapy: Implications for the Organization of Stroke Systems of Care

    Monday, May 11, 2015  Research

    Endovascular acute ischemic stroke therapy is now proven by randomized controlled trials to produce large, clinically meaningful benefits. In response, stroke systems of care must change to increase timely and equitable access to this therapy. In this review, we provide a North American perspective on implications for stroke systems, focusing on the United States and Canada, accompanied by initial recommendations for changes.

  • Supporting Stroke Services

    Friday, May 1, 2015  Mass General

    Lee H. Schwamm, MD, executive vice chairman of Neurology and director of the Mass General Stroke Service, shares information about strokes, warning signs and advances in stroke care.

  • Neurology residents practice what they preach

    Friday, March 6, 2015  Mass General

    Several MGH and MassGeneral Hospital for Children (MGHfC) neurologists are saying goodbye to carbohydrates and sweets for the month. In order to support their patients, spread awareness about the effectiveness of dietary therapy and raise funds for the department, six neurologists – both pediatric and adult – are participating in a Low Glycemic Index Therapy (LGIT) diet, which often is used in the treatment of pediatric epilepsy patients.

  • The Division of Sleep Medicine Receives Program Accreditation

    Friday, February 27, 2015  Mass General

    The Division of Sleep Medicine at Massachusetts General Hospital in Boston recently received program accreditation from the American Academy of Sleep Medicine (AASM).

  • New year, better sleep

    Friday, January 16, 2015  Mass General

    Better sleep is a resolution that should be on everyone’s list, according to Josna Adusumilli, MD, an MGH neurologist and sleep specialist. But when it comes to sleep, how much is enough and what is the best way to get restful sleep? Adusumilli explains.

  • Increasing Surgical Options for Epilepsy Patients

    Thursday, January 1, 2015  Clinical

    Advances in pre-surgical evaluation methods have made it possible to more accurately identify the epileptogenic region and minimize risk of injury to the functional cortex, enabling more epilepsy patients to receive surgical treatment.

Currently Browsing:2014

  • Earlier tPA Treatment for Ischemic Stroke

    Monday, December 1, 2014  Mass General

    Massachusetts General Hospital researchers joined hospitals from around the country to demonstrate the effectiveness of a treatment for ischemic stroke and create a set of standards to expedite treatment delivery.

  • Mass General Neuroendovascular Care: New Technologies Help to Save Lives

    Wednesday, November 19, 2014  Mass General

    “Every patient's problems, risk factors and social situations are so individual. Treatment should be individually tailored to best meet their needs and expectations” says Dr. Leslie-Mazwi.

  • Sleep Research: Do Try This At Home

    Tuesday, November 18, 2014  Clinical

    About 10 percent of Americans suffer from sleep apnea, a disorder of nighttime breathing that disrupts sleep but often goes undiagnosed. Apnea can lead to daytime drowsiness, which puts people at risk of accidents and injuries. Poor sleep due to apnea or other causes also raises the chances of developing high blood pressure, diabetes, depression, heart disease and stroke.

  • NeuroBlast e-Newsletter June 2014

    Saturday, November 1, 2014  Mass General

    This issue examines the latest trends in Epilepsy research, clinical care and neurosurgery.

  • Russell Museum Fall Lecture Series

    Thursday, September 11, 2014  Mass General

    All MGH Russell Museum lectures are open to the public. To register, please email

  • Decompressing After School: Students with an Autism Spectrum Disorder

    Monday, September 8, 2014  Mass General

    Many children and teens on the autism spectrum expend a lot of energy to “hold it together” just to make it through the school day. When they get home from school they could benefit from a little time to decompress. Here are strategies parents can use to help facilitate this process.

  • Slaugenhaupt named scientific director of MGH Research Institute

    Friday, August 22, 2014  Mass General

    Susan Slaugenhaupt, PhD, of the MGH Center for Human Genetic Research and professor in the Department of Neurology, has been named the first scientific director of the MGH Research Institute.

  • Albers honored with Wilkens endowed chair

    Friday, August 22, 2014  Mass General

    Mark Albers, MD, PhD, of the Department of Neurology, was named the first incumbent of the Frank Wilkens, Jr. and Family Endowed Chair in Alzheimer’s Disease Research.

  • Fundraising and fighting for a cure

    Friday, August 15, 2014  Mass General

    In 2012, when 30-year-old Quincy resident Alex Cellucci was nine months pregnant, she was diagnosed with neurofibromatosis, a genetic disorder that disturbs cell growth in the nervous system, enabling tumors to grow on any nerve in the body.

  • #1 in New England, #2 in the nation

    Tuesday, July 15, 2014  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

  • NeuroBlast e-Newsletter

    Tuesday, June 24, 2014  Clinical

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • New device brings hope to epilepsy patients

    Thursday, June 19, 2014  Mass General

    After years of seizures, a new device gives one Mass General epilepsy patient a new lease on life.

  • Every second counts

    Friday, June 13, 2014  Mass General

    When it comes to treating stroke patients, every second counts.

  • The MGH Epilepsy Service – Where Complexity Meets Innovation

    Wednesday, June 4, 2014  Mass General

    A young Albanian architect found help for his seizure disorders thanks to a unique team of specialists from the Department of Neurology at Massachusetts General Hospital.

  • Will New Research Redefine Epilepsy?

    Wednesday, May 28, 2014  Mass General

    Recent research is challenging the traditional definition of epilepsy as an expression of increased excitability and firing of a group of neurons. This has major implications for clinical treatment.

  • The MGH Epilepsy Service – Where Complexity Meets Innovation

    Tuesday, May 27, 2014  Mass General

    When Elton, a young Albanian architect, couldn’t find treatment for his disabling seizures in Albania, he traveled 500 miles to Austria to meet with Massachusetts General Hospital (MGH) Epilepsy Service Director Andrew J. Cole, MD. Dr. Cole, in Austria on a business trip, felt Elton was a good candidate for surgery and brought his case back to his colleagues in Boston.

  • Northeast ALS Consortium (NEALS) Website Offers Resources for Patients and Researchers

    Friday, January 31, 2014  Research

    The Northeast ALS Consortium (NEALS) website is devoted to supporting clinical research of Amyotrophic Lateral Sclerosis (ALS) and other motor neuron disease (MND).

  • ALS Clinical Trials Liaison Available to Help Connect PALS With Clinical Research Information

    Thursday, January 30, 2014  Research

    NEALS and ALSA partner to offer clinical trial liaison service to help people with ALS navigate the world of clinical research.

Currently Browsing:2013

  • Alzheimer’s Disease Gene Discovery & Drug Discovery

    Wednesday, December 11, 2013  Research

    “This is the largest collection of familial Alzheimer’s whole-genome sequences in the world,” Dr. Tanzi says, comprising half a petabyte of data, equivalent to the entire contents of the Library of Congress. “This is as big as big data gets.” 

  • Spinal Metastases & Stereotactic Radiosurgery

    Tuesday, December 10, 2013  Clinical

    Radiosurgery has shifted the paradigm of treating patients by minimizing the morbidity of conventional surgery and, focusing on tumor control.

  • Dietary Therapy for Pediatric Epilepsy

    Tuesday, December 10, 2013  Mass General

    Dietary therapy is prescribed most often for patients with refractory epilepsy, whose seizures have not been controlled despite trying multiple antiepileptic drugs.

  • Tau Pathology Spreading out from the Entorhinal Cortex Can be Reversed

    Tuesday, December 10, 2013  Research

    Neurofibrillary tangles - largely composed of tau protein- are one of the two pathological hallmarks of Alzheimer’s disease.

  • Alzheimer's Early Treatment

    Tuesday, December 10, 2013  Research

    Can anti-amyloid antibody treatment reverse Alzheimer’s disease pathology before memory loss sets in?

  • Alzheimer's Preclinical Disease Biomarker

    Tuesday, December 10, 2013  Research

    Mark Albers, MD, PhD, is developing a set of simple but powerful tools to screen for the very earliest stages of preclinical Alzheimer’s Disease.

  • NeuroBlast e-Newsletter December 2013

    Tuesday, December 10, 2013  Mass General

    In this issue: spinal metastases & stereotactic radiosurgery; skull base tumors & endoscopic surgery; pediatric epilepsy dietary therapy; Alzheimer Disease: tau pathology; drug & gene discovery; early treatment; preclinical diagnostic tools.

  • Strides in Understanding and Treating ALS

    Sunday, December 1, 2013  Mass General

    The Northeast ALS Consortium, co-founded by Massachusetts General Hospital researcher Merit Cudkowicz, MD, has spurred basic and translational research that has led to investigational therapies and improved patient outcomes.

  • "The Art of Illness"

    Friday, November 1, 2013  Mass General

    Paul S. Russell, MD Museum of Medical History and Innovation invites you to attend its latest lecture in its evening series

  • Use of clot-dissolving drug for ischemic stroke nearly doubled from 2003 to 2011.

    Friday, August 30, 2013  Mass General

    A team of researchers reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.

  • Neurology Infusion Center: A feeling of family

    Friday, August 16, 2013  Mass General

    The MGH Neurology Infusion Center is an ambulatory outpatient unit that delivers infusion and intravenous (IV) services to patients, ages 18 and older, who have a variety of neurological disorders. On average, the unit sees 12 to 14 patients per day but more referrals from MGH clinicians for ambulatory patients are welcome.

  • A brain cancer "warrior" takes the trip of a lifetime

    Wednesday, July 31, 2013  Mass General

    Mass General patient Michelle Beale's journey started with debilitating headaches. Now she's traveling around the world.

  • Concussion

    Monday, July 22, 2013  Clinical

    When neurosurgeon Tina Duhaime, MD, of the MGH Youth Sports Concussion Clinic, talks with families about concussion, she takes time to explain what is known, and just as importantly, what isn’t known, about this common injury.

  • TeleStroke: Real-time Resources for Better Patient Care

    Monday, July 22, 2013  Clinical

    Through the TeleStroke network, 30 emergency departments across the northeast have real-time access to stroke experts 24 hours a day, seven days a week.

  • E Pluribus Unum for Parkinson Disease - Researchers Draw on Sources to Improve Treatment of PD

    Monday, July 22, 2013  Clinical

    What do Gaucher’s disease, gout, and amyloid plaques have in common? For researchers at the MGH, each of them may shed light on the causes and treatment of Parkinson’s disease.

  • NeuroBlast e-Newsletter

    Monday, July 22, 2013  Clinical

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • #1 in New England, #2 in the nation

    Tuesday, July 16, 2013  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

  • It takes a team

    Friday, June 28, 2013  Mass General

    The MGH Acute Stroke Care Team was honored with the 2012 Acute Stroke Champion Award at the MGH Acute Stroke Gala Breakfast.

  • Informatics Core at MIND: Building Tools, Creating Connections

    Thursday, March 14, 2013  Research

    The Informatics Core at MIND offers state-of-the-art bioinformatics services, connecting researchers with tools, each other, and expertise to manage their clinical and research databases.

  • Lessons learned through pages turned

    Friday, January 25, 2013  Mass General

    When it came time for Bryn Seltzer, 13, of Needham, to choose her bat mitzvah project, she knew she wanted to give back to the Pediatric Epilepsy Program at MassGeneral Hospital for Children (MGHfC), which had cared for her since she was 6 years old.

Currently Browsing:2012

  • Cure Alzheimer’s Fund donates $5.4 million

    Friday, October 26, 2012  Mass General

    On Oct. 18, at a press conference in Cambridge, the Cure Alzheimer’s Fund announced a fitting $5.4 million contribution to the MGH to fund state-of-the-art whole genome DNA sequencing that aims to enhance understanding of the genetic roots of Alzheimer’s.

  • New neurology chief shares lessons

    Friday, October 5, 2012  Mass General

    The 15th Annual Women in Medicine Month Celebration on Sept. 20 featured a keynote lecture by Merit Cudkowicz, MD, chief of Neurology.

  • Boosting metabolism at work

    Friday, August 10, 2012  Mass General

    Research has shown that sitting for extended periods may not only negatively affect health but also may prematurely shorten lifespan. Marie Pasinski, MD, offers five ways to incorporate more activity into the workday.

  • All’s Quiet on the Lunder Floors

    Monday, July 16, 2012  Mass General

    The Lunder Building is leading a noise-reduction revolution. Thanks to careful planning and innovative thinking, patients rest and receive treatment in a quiet healing environment.

  • Not Your Typical Rash: Why Shingles Can't Be Taken Lightly

    Thursday, May 31, 2012  Mass General

    Anne Louise Oaklander, MD, PhD, associate professor of Neurology, says shingles and post-herpetic neuralgia (PHN), a serious neurological complication in which pain lingers in an area of previous shingles long after the rash heals, cannot be taken lightly. PHN can last for months or years and is a source of severe and disabling pain, particularly for older patients.

  • Mind over matter

    Friday, May 25, 2012  Mass General

    Nearly 15 years after a stroke left her paralyzed and unable to speak, 59-year-old Cathy Hutchinson controlled a robotic arm to lift coffee to her mouth and take a drink by thinking about moving her own arm.

  • 2012 Research Scholars announced

    Friday, May 25, 2012  Mass General

    The second group of MGH Research Scholars – recipients of unrestricted five-year grants to support innovative investigations – was announced at the hospital’s Research Advisory Council (RAC) annual meeting on May 11.

  • Responsibility with a smile

    Friday, May 4, 2012  Mass General

    In her 30 years as a member of the Child Neurology Department, Ginny Tosney-Trask has “become legendary for her humanity, warmth and generosity.”

  • In Memoriam: C. Miller Fisher, MD

    Friday, April 20, 2012  Mass General

    C. Miller Fisher, MD, founder of the MGH Stroke Service and widely regarded as the father of stroke neurology, died April 14 at the age of 98.

  • Appointments announced

    Friday, March 23, 2012  Mass General

    THE MGH WILL WELCOME new chiefs for the Department of Neurology and the Department of Urology later this spring.

Currently Browsing:2011

  • MGH ranks #2 in nation

    Tuesday, July 19, 2011  Mass General

    MGH ranks #2 in 2011-2012 U.S. News & World Report "Best Hospitals" rankings

  • Care redesign teams move forward with recommendations

    Friday, July 1, 2011  Mass General

    The Partners Strategic Initiative is an ongoing effort to improve care and increase efficiency across all Partners institutions, including the MGH.

  • Third Annual Tarbell Lecture features Anne B. Young, MD, PhD

    Friday, June 10, 2011  Mass General

    MGH Hotline 6.10.11 A world-renowned neurological researcher and clinician who has helped break down barriers for women in her field, Anne B. Young, MD, PhD, chief of the Department of Neurology, has a great deal of wisdom and insight to offer to colleagues.

  • Anne Young, MD, PhD, donates $1M to Department of Neurology

    Friday, April 8, 2011  Mass General

    ANNE YOUNG, MD, PHD, chief of Neurology, made history for women in academic medicine by making a $1 million gift to the Department of Neurology through a deferred charitable gift annuity.

  • Lunder Building patient floors enhance patient- and family-oriented care

    Friday, March 11, 2011  Mass General

    The top five floors of the Lunder Building are dedicated adult inpatient units for neuroscience and cancer patients. While the patient floors follow a standard design, each has highlights specific to a particular patient population. This week, MGH Hotline will highlight unique features of Floors 6 through 8, which are devoted to neuroscience patients, and provide a general description of a Lunder Building inpatient room. A subsequent issue will focus on Floors 9 and 10, which are dedicated to cancer patients, and will highlight the Lunder Building’s nursing, support services and common areas.

  • Lunder Building to "Go Live" this summer

    Friday, February 18, 2011  Mass General

    MGH Hotline 2.18.11 In preparation for the summertime transition of several hospital programs and services to the Lunder Building, the MGH Go Live Group for the new facility was established under the auspices of Jean Elrick, MD, senior vice president for Administration.

  • Acute Stroke Quality Task Force recognizes fastest treatment time

    Friday, February 4, 2011  Mass General

    MGH Hotline 02.04.11 TIME IS BRAIN when it comes to treating stroke.

Currently Browsing:2010

  • MGH ranks among top

    Friday, July 16, 2010  Mass General

    The MGH ranked third among the country's top hospitals on the annual list of "America's Best Hospitals" issue of U.S. News & World Report.

  • MGH residents and fellows make great save during soccer game

    Friday, July 16, 2010  Mass General

    SPAIN MAY HAVE WON the World Cup, but a team of MGH medical residents and fellows had a victory of their own on the soccer field this summer when they helped save the life of another player.

  • Overcoming the odds

    Friday, May 28, 2010  Mass General

    MGH Hotline 5.28.10

  • Surviving a brain stem stroke

    Wednesday, March 10, 2010  Mass General

    Stroke is one of the leading causes of serious, long-term disability in the United States. The Stroke Service at the Massachusetts General Hospital Vascular Center successfully treat one of emergency medicine’s toughest stroke cases.

  • Cutting-edge research, industry-changing model of care improves the lives of patients

    Thursday, January 7, 2010  Clinical

    Duchenne muscular dystrophy (DMD) is the most prevalent and aggressive type of muscular dystrophy, affecting one in every 3,500 live male births in the world. It is also one of the most common lethal genetic diseases of children worldwide.

Currently Browsing:2009

  • In Memoriam: Lisa Krivickas, MD

    Friday, October 2, 2009  Mass General

    MGH Hotline 10.02.09 Lisa Krivickas, MD, associate chief of the MGH Department of Physical Medicine and Rehabilitation and a physician in the Department of Neurology, died of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, Sept. 22 at the age of 45.

  • Tuberous Sclerosis Complex

    Tuesday, July 21, 2009  Mass General

    The Carol and James Herscot Center for Tuberous Sclerosis Complex (TSC) at Massachusetts General Hospital and MassGeneral Hospital for Children is using genetic research to better understand TSC and other diseases like cancer, autism and obesity.

  • Turning thoughts into action

    Monday, June 15, 2009  Mass General

    Dr. Leigh Hochberg from the Department of Neurology at Massachusetts General Hospital is using neurotechnology to harness brain signals that accompany movement. The ultimate goal of the work is to "turn thought into action," with the hope of one day assisting people with ALS, spinal cord injury and stroke to regain control over their environment.

  • Videoconferencing can increase patient access to stroke specialists

    Monday, May 18, 2009  Mass General

    Massachusetts General Hospital neurologist Dr. Lee Schwamm leads a national policy endorsing telestroke as an effective means of stroke evaluation.

Currently Browsing:2008

  • Home for Christmas

    Friday, December 19, 2008  Clinical

    One year ago, a team of intensive care experts at Massachusetts General Hospital collaborated to save Karla Leavenworth's life.

  • New screening tool for identifying major depression in patients with epilepsy

    Monday, September 15, 2008  Mass General

    Commentary on NDDI-E screening tool for detecting symptoms of major depression, while excluding adverse effects of antiepileptic drugs or temporal lobe epilepsy memory problems

Press Releases

Currently Browsing:2019

Currently Browsing:2018

Currently Browsing:2017

Currently Browsing:2016

Currently Browsing:2015

Currently Browsing:2014

  • Study identifies potential treatment target for cocaine addiction - 10/29/2014, Research

    Investigators from MGH and the Perelman School of Medicine at the University of Pennsylvania have identified a potential target for therapies to treat cocaine addiction. Their study finds evidence that a small change in an important protein alters whether cocaine-experienced animals will resume drug seeking after a period of drug abstinence.

  • MGH and MIT form strategic partnership to address major challenges in clinical medicine - 10/15/2014, Research

    A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases.

  • Novel culture system replicates course of Alzheimer’s disease, confirms amyloid hypothesis - 10/12/2014, Research

    An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer’s disease. Using the system they developed, MGH investigators provide the first clear evidence supporting the hypothesis that deposition of beta-amyloid plaques in the brain is the first step in a cascade leading to the devastating neurodegenerative disease.

  • In recognizing speech sounds, the brain does not work the way a computer does - 4/30/2014, Research

    How does the brain decide whether something is correct? When it comes to the processing of spoken language, the theory has been that the brain applies a set of rules to determine which combinations of sounds are permissible. Now the work of MGH investigators suggests that the brain decides based on the words that are already known.

  • High-calorie feeding may slow progression of ALS - 2/27/2014, Research

    Increasing the number of calories consumed by patients with amyotrophic lateral sclerosis (ALS) may be a relatively simple way of extending their survival. A phase 2 clinical trial led by Massachusetts General Hospital physicians found that ALS patients receiving a high-calorie, high-carbohydrate tube-feeding formula lived longer with fewer adverse events than participants who received a standard formula designed maintain their weight.

  • First Huntington disease prevention trial shows treatment safety, suggests slowing of presymptomatic progression - 2/7/2014, Research

    The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants. In addition, neuroimaging provided evidence that creatine might slow the progression of presymptomatic disease.

Currently Browsing:2013

Currently Browsing:2012

Currently Browsing:2011

Currently Browsing:2010

Currently Browsing:2009

  • New Web Tool May Help Predict Risk of Second Stroke - 12/16/2009, Research

    Scientists have developed a new web-based tool that may better predict whether a person will suffer a second stroke within 90 days of a first stroke.

  • Study supports possible role of urate in slowing Parkinson’s disease progression - 10/12/2009, Research

    By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases and Harvard School of Public Health, has found evidence supporting the findings of their 2008 study – that elevated levels of the antioxidant urate may slow the progression of Parkinson’s disease.

  • MassGeneral Hospital for Children study explains some mysteries of neonatal seizures - 9/9/2009, Research

    A study led by MassGeneral Hospital for Children investigators is providing new insight into the mechanism of neonatal seizures, which have features very different from seizures in older children and adults.

  • Antiangiogenesis treatment improves hearing in some NF2 patients - 7/8/2009, Research

    Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). The study by researchers from Massachusetts General Hospital (MGH) represents the first report of a successful NF2 treatment not involving surgery or radiation.

  • Mass. General's Rudy Tanzi a "Rock Star of Science" - 5/26/2009, Research

    Alzheimer’s disease researcher Rudolph Tanzi, PhD, of Massachusetts General Hospital adds another distinction to his scientific career when he joins Aerosmith’s Joe Perry and other rock celebrities in a designer menswear photo shoot as a “Rock Star of Science” in the June issue of GQ Magazine.

  • Videoconferencing can increase patient access to stroke specialists - 5/8/2009, Research

    High-quality videoconferencing can increase patient access to stroke specialists; and a transient ischemic attack, once known as a “mini” or “warning” stroke, should be treated with the same urgency as a full-blown stroke, according to two separate statements published today in Stroke.

  • Modification of mutant huntingtin protein increases its clearance from brain cells - 4/2/2009, Research

    A new study has identified a potential strategy for removing the abnormal protein that causes Huntington’s disease from brain cells, which could slow the progression of the devastating neurological disorder.

  • Alzheimer’s-associated plaques may have impact throughout the brain - 2/26/2009, Research

    The impact of the amyloid plaques that appear in the brains of patients with Alzheimer’s disease may extend beyond the deposits’ effects on neurons– the cells that transmit electrochemical signals throughout the nervous system.

  • International collaboration identifies new gene associated with ALS - 2/26/2009, Research

    A collaborative research effort spanning nearly a decade between researchers at Massachusetts General Hospital and King’s College London has identified a novel gene for inherited amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease).


Currently Browsing:2019

Currently Browsing:2018

Currently Browsing:2017

Currently Browsing:2016

  • Neurological Emergencies

    Thursday, September 22, 2016

    When patients complain of headache, dizziness, weakness or back pain, how do you determine which is an emergency? This special program provides state-of-the-art approaches and tools to quickly and effectively determine which cases are emergencies, and how to treat them.
  • MGH Pediatric Epilepsy Program's Annual Taking Epilepsy to College

    Tuesday, June 28, 2016

    Massachusetts General Hospital, 32 Fruit Street, Boston, Mass. Yawkey Outpatient Center - 2nd Floor: Room 2-210 for Students and Room 2-220 for Parents
  • Dementia: A Comprehensive Update

    Wednesday, June 8, 2016

    The spectrum of neurodegenerative diseases spans from very mild cognitive impairment to frank dementia. Alzheimer’s disease (AD), the most common cause of dementia, is a devastating condition that affects patients and their whole family of caregivers at tremendous emotional as well as financial cost.
  • Jake's Ride

    Sunday, May 1, 2016

    Please join us on Sunday, May 1, 2016, in Short Hills, NJ for Jake’s Ride! A generous portion of the funds raised will go to support Movement Disorder Fellowship training at here at Mass General!

Currently Browsing:2015

Currently Browsing:2014

Currently Browsing:2013

  • "The Art of Illness"

    Tuesday, November 12, 2013

    The Massachusetts General Hospital Paul S. Russell, MD Museum of Medical History and Innovation Lecture Series invites you to attend the next in its series of free monthly evening lectures.
  • Beautiful Brain with Marie Pasinski, MD

    Wednesday, March 6, 2013

    Harvard neurologist, Dr. Marie Pasinski, MD will talk about keeping your brain healthy.

Currently Browsing:2012


  • Video about Parkinson's and LBD research

    Parkinson's Symposium at MIND- 2008

    Momentum in our Pursuit of Cures - Research advances in Parkinson's, Lewy Body dementia, and Parkinson's-Plus disorders. Anne B. Young, MD, PhD, Director, MassGeneral Institute for Neurodegenerative Disease (MIND), formerly Chief of Neurology Service.

  • Guy Rordorf, MD, recommends an imaging test for anyone with a family history of FMD

    Guy Rordorf, MD, recommends an imaging test for anyone with a family history of FMD

    Guy Rordorf, MD, vascular neurologist at the Massachusetts General Hospital Fireman Vascular Center, says an imaging test can detect fibromuscular dysplasia (FMD), and recommends it for those with a family history of the condition. Learn more about FMD and how it weakens artery walls and can lead to severe hypertension or stroke.

  • Celebrating 200 Years: 1811 - 2011

    Celebrating 200 Years: 1811 - 2011

    Since 1811, people have counted on Mass General for answers, innovations and medical leadership. As our third century dawns, we remain ready to serve.

  • Ceftriaxone in ALS Webinar

    The Clinical Trial of Ceftriaxone in ALS

    A webinar recording explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Ceftriaxone in ALS Video

    Ceftriaxone Trial Video

    A video explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration, 2011 Part I

    Neurology Bicentennial Celebration, October 13, 2011. Past History of MGH Neurology; Overview of MGH Neurology; Telestroke and Acute Stroke Service; Neurodegenerative Disorders; Pediatric Neurology.

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration, 2011 Part II

    Neurology Bicentennial Celebration, October 13, 2011. Clinical and research presentations on ALS, Stroke, Alzheimer’s Disease, and Parkinson’s Disease

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration 2011 II HD

    Neurology Bicentennial Celebration, October 13, 2011. Clinical and research presentations on Huntington’s Disease, Epilepsy, and Neuro-Oncology.

  • respiratory assistance video

    Respiratory Assistance Video

    A video for ALS patients discussing and demonstrating uses of bipap and cough assist machines.

  • Young stroke victim recovers from basilar artery occlusion

    A young stroke victim experiences a dramatic recovery

    A young stroke victim experiences a dramatic recovery from a life threatening basilar artery occlusion with the help of the Acute Stroke Team and Dr. Aneesh Singhal. Also featuring Dr. Lee Schwamm.

  • A young epileptic patient regains normalcy

    Treatment for epileptic seizures in young patient

    Treatment for epileptic seizures with Dr. Thiele and brain surgery performed by Dr. Duhaime help this young epileptic patient regain normalcy after experiencing up to 12 seizures daily.

  • young man recovers from seizures and coma

    A young man recovers from seizures and coma

    The Neuro Critical Care Team’s excellence in service and innovation bring a young man back to life after epileptic seizures leave him comatose for five months. Features Dr. Rosand and Dr. Cole.

  • Frontal Temporal Dementia

    Patient diagnosed with Frontal Temporal Dementia

    A gripping story of a young man diagnosed with Frontal Temporal Dementia by Dr. Brad Dickerson.

  • Dr. Marie Pasinski speaking with a monk

    Community Health

    MGH doctors Nicte Mejia-Gonzalez and Marie Pasinski talk about providing neurological care to patients at MGH Community Health Care centers.

  • Partners Neurology Residents at Mass General

    Partners Neurology Residency

    Neurology residents, program graduates, faculty members, and the education director talk about training at Mass General Hospital and Brigham and Women’s Hospital.

  • Mr. Elton

    Epilepsy: The Road to a Cure

    A young man's quest to find a cure for his epileptic seizures takes him on a journey from Albania to Boston.

  • Welcome for Patients

    ALS Patient Video

    Nicole from Boston, shares her story about her battle with ALS and her strong desire to help others with the disease in the future. Mass General's ALS Multidisciplinary Clinic provides the latest treatments and research opportunities for people with Amyotrophic Lateral Sclerosis.

  • Dr. Cudkowicz

    Patient Welcome from Dr. Cudkowicz

    Dr. Merit Cudkowicz, Neurology's Chief of Service, shares what makes the Mass General ALS Multidisciplinary Clinic so special.

  • Acute Stroke Care: When Time is Critical

    Acute Stroke Care: When Time is Critical

    13 days after giving birth to her son, a young woman suffers a stroke and makes a miraculous recovery. Features Dr. Leslie-Mazwi, Dr. Mehta and Dr. Musolino.Acute Stroke Care: When Time is Critical

  • Dr. Merit Cudkowicz, recipient of MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz, MGH Neurology Department Chairperson and Director, MGH ALS Clinic, for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD. This award is given to a researcher, physician, or clinician who supports MDA/ALS research initiatives and clinical services and continues to fight the battle against ALS. View her acceptance speech where she discusses reasons for hope in the future of ALS treatments.

  • ALS Symposium

    MGH ALS Symposium Video

    Hear from the MGH Neurology Department Chairperson and founder and member of the MGH ALS Multidisciplinary Clinic, Dr. Merit Cudkowicz; Director of the MGH Multidisciplinary Care Clinic, Dr. James Berry; as well as the many researchers and clinic staff dedicated to finding treatments and cures for ALS.

  • ALS Walk of Hope

    ALS Walk of Hope

    Learn how the Walk of Hope, sponsored by the ALS Raising Hope Foundation ( raises funds for neurodegenerative disease research at MIND-and how researchers are using it to find cures.

  • Dylan and Family

    Dr. Brian Edlow, with former patient Dylan Rizzo and parents in the NeuroICU last week. Dylan is a former patient of Dr. Edlow's, who returned to talk to faculty at Thursday's noon conference about his unexpected recovery from a severe traumatic brain injury.

  • Jessica’s Story: A Stroke Survivor

    Jessica's Story: A Stroke Survivor

    Jessica Diaz had a stroke caused by a small hole in the heart, which had allowed a blood clot to travel to her brain. As a young and active mother of two, Jessica worked with a team of Mass General doctors to not only repair her heart, but determine a treatment plan to minimize future health risks.

  • Diagnosing TSC

    Diagnosing TSC

    Neurologist Elizabeth Thiele explains that diagnosis of TSC is based on the clinical features common in the disorder.

  • ALS House Call Launch Event

    ALS House Call Launch Event

    Watch MGH physicians Tim Ferris, MD, Merit Cudkowicz, MD, and James Berry, MD speak at the ALS House Call program launch event.

  • August 23, 2018 ALS Webinar

    Radicava updates for patients and families

    August 23, 2018 ALS Webinar

  • 4th Annual ALS Care and Research Symposium

    Your Day: 4th Annual ALS Care and Research Symposium

    Watch presentations on the newest updates in ALS patient and caregiver clinical care and research.

  • After Lunch Series video

    After Lunch Series: Welcome to Our House - Tips & Tricks for Navigating Your Home

    The “After Lunch Series” of webinars are a new initiative, led by the MGH-ALS Nurses, to provide a forum for discussion about common interventions and treatments for people living with ALS.

  • Serving Up Cals for pALS

    Serving Up Cals for pALS – a webinar from the After Lunch Series with MGH ALS nurses for ALS patients. The “After Lunch Series” of webinars are a new initiative, led by the MGH-ALS Nurses, to provide a forum for discussion about common interventions and treatments for people living with ALS.


Innovations in ALS Clinical Trials at Mass General

Dr. Merit Cudkowicz, Chief of Neurology at Mass General Hospital discusses innovations in ALS clinical trials since she started in the field in 1994.

Back to Top